Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Dain

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiolA Gauthier, D Upmalis, M P Dain
Presse Medicale (Paris, France : 1983)|October 4, 1984
[Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo]B Paramelle, C Joubert, M P Dain
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1988
Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosisJ P Chazalette, M P Dain, J P Castaigne
International Journal of Fertility and Menopausal Studies|January 1, 1993
Effects on blood lipid and androgen levels of two triphasic oral contraceptivesA Janaud, J Rouffy, D Upmalis, et al.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrelA Janaud, J Rouffy, D Upmalis, et al.
Diabetes, Obesity & Metabolism|March 18, 2011
Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetesG G Rhoads, M P Dain, Q Zhang, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy studyJ W Studd, K MacCarthy, D Zamblera, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|January 1, 1989
Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative studyH Gouerou, M P Dain, I Parrondo, et al.
Obstetrics and Gynecology|October 8, 1999
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study GroupD F Archer, K Furst, D Tipping, et al.
Diabetes Research and Clinical Practice|October 4, 2011
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetesG C Hall, A D McMahon, M-P Dain, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiolA Gauthier, D Upmalis, M P Dain
Presse Medicale (Paris, France : 1983)|October 4, 1984
[Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo]B Paramelle, C Joubert, M P Dain
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1988
Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosisJ P Chazalette, M P Dain, J P Castaigne
International Journal of Fertility and Menopausal Studies|January 1, 1993
Effects on blood lipid and androgen levels of two triphasic oral contraceptivesA Janaud, J Rouffy, D Upmalis, et al.
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1992
A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrelA Janaud, J Rouffy, D Upmalis, et al.
Diabetes, Obesity & Metabolism|March 18, 2011
Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetesG G Rhoads, M P Dain, Q Zhang, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy studyJ W Studd, K MacCarthy, D Zamblera, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology|January 1, 1989
Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative studyH Gouerou, M P Dain, I Parrondo, et al.
Obstetrics and Gynecology|October 8, 1999
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study GroupD F Archer, K Furst, D Tipping, et al.
Diabetes Research and Clinical Practice|October 4, 2011
A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetesG C Hall, A D McMahon, M-P Dain, et al.
Pageof 3